𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemiluminescence sandwich enzyme immunoassay for determination of human granulocyte colony stimulating factor (G-CSF)

✍ Scribed by Aoyagi, Shigeo ;Arasawa, Kazue ;Matsuyuki, Akira ;Kamatchi, Shin-ichi ;Fukushima, Masafumi ;Ohsawa, Nakaaki


Publisher
John Wiley and Sons
Year
1995
Weight
432 KB
Volume
10
Category
Article
ISSN
0884-3996

No coin nor oath required. For personal study only.

✦ Synopsis


A chemiluminescence sandwich enzyme immunoassay, using a glucose oxidase (GO) label, was developed for detecting attomole amounts o f human granulocyte colony stimulating factor (G-CSF). Purified goat F(ab')* immobilized on a bead and purified goat Fab' labelled with GO were selected in combination w i t h a chemiluminescent detection system comprising luminol and ferricyanide. The detection limits for G-CSF were 4amol/assay (1 pg/mL) in buffer solution and lOamol/assay (2.5 pg/mL) in human serum. Coefficients o f variation within assay and between assay ranged from 5.5% t o 7.8% and from 3.4% t o 16.0%. respectively. The G-CSF content of serum from normal healthy individuals was measurable using this method. G-CSF in 24 normal human sera showed a mean value o f 19.3pg/mL and ranged from 3.6 t o 83.0 pg/mL.


πŸ“œ SIMILAR VOLUMES


Recombinant human granulocyte colony-sti
✍ Takahashi, Satoshi; Oshima, Yasuo; Okamoto, Shin-ichiro; Nishiwaki, Kaichi; Naga πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 1 views

We previously suggested that using a combined conditioning regimen including rhG-CSF with allogeneic BMT in refractory AML and CML in blast crisis might reduce the rate of relapse and improve disease-free survival, without any major side effects. In this study, we used the same protocol for 10 AML p

Granulocytic colony-stimulating factor (
✍ Ralph M. BΓΆhmer; Antony W. Burgess πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 638 KB

It has been reported previously that cells of the murine myelomonocytic leukaemia cell line WEH13B(D+) can be induced to differentiate into mature monocytes by incubation with post-endotoxin serum (ES), granulocyte-colony-stimulating factor (G-CSF) or actinomycin D (AMD). We have investigated the ki

Pharmacokinetics of intravenous recombin
✍ Sturgill, Marc G.; Huhn, Richard D.; Drachtman, Richard A.; Ettinger, Alice G.; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 2 views

Limited evidence suggests increased efficacy of rhG-CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that rapid elimination of IV rhG-CSF could substantially shorten the duration of systemic exposure and could explain a difference in pharmacodynamics

A phase I trial to assess the value of r
✍ G. M. Smith; J. A. Child; M. H. Cullen; N. P. Bailey; C. M. Woodruffe; J. Fletch πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 571 KB

In a multi-centre phase I study we investigated the possibility of reducing the interval between courses of standard CHOP (cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m', vincristine 2 mgs day 1, and prednisolone 40mglm' days 1-8) from 21 days to 15 days and then 10 days using granulocyte colony s